These products occupy a unique regulatory space as non-FDA-approved "New Animal Drugs." That said, veterinarians can legally utilize them through clinical discretion within a valid Veterinary-Client-Patient Relationship (VCPR) with full and complete disclosure concerning these therapeutic tools, as they do with any existing therapeutic tool, particularly off label use. Practitioners should consult their legal advisors and ensure that any claims are not false, deceptive or misleading. For instance, framing these treatments as "supportive therapies" or "adjunctive care" rather than definitive cures is an option to consider. VetBiologix provides high-purity, verified substances from manufactures that are verified for their commitment to quality and safety, and supplies both certificates of analysis (COAs) and third-party testing outcomes.

Practitioners are encouraged to utilize standardized documentation such as Patient Intake and Informed Consent templates. VetBioLogix makes an example of one available to all customers. Complete and thorough disclosure of the nature of the therapies and consent to treatment prior to treatment are critical to professional integrity. Additionally, implementing a Clinical Tracking Log—incorporating baseline metrics like lameness scores, precise dosing protocols, and scheduled follow-up assessments—allows for the diligent monitoring of patient safety and progress in a field where longitudinal data is being gathered.

BPC-157 100mg and TB-500 100mg are single-ingredient vials. The Blend 50/50mg contains both ingredients in the same vial at 50mg/50mg.

Yes. Certificates of Analysis are available by batch upon request.

VetBioLogix supports lot-level quality documentation. COAs can be requested for verification of batch details.

Our current protocols are informed by ongoing clinical studies, pilot data, and real-world veterinary feedback. They are intended as flexible clinical guidelines rather than rigid mandates. Because peptide therapy is an emerging technology fueled by customer/patient demand, we encourage practitioners to exercise both clinical leadership and judgment by ensuring proper informed consent procedures, tailoring dosage and frequency to each patient’s specific weight, injury severity, and metabolic response and tracking pre and post treatment data for each such patient. VetBiologix remains committed to an "Evidence-Based Evolution," continuously refining these guidelines as more species-specific data and longitudinal results become available.

Store according to the label and your clinic’s standard handling procedures. Refer to batch documentation for specific storage guidance.

Orders typically ship within 1–2 business days after verification and payment.

International shipping availability depends on destination and regulatory requirements. Contact support to confirm eligibility.

Accepted payment methods are displayed during checkout.